Pharmacokinetics of verapamil and its metabolite norverapamil from a buccal drug formulation

International Journal of Pharmaceutics

Volumn 238, Issue 1-2, 2002, Pages 181-189

  Sawicki, Wiesław ^a   Janicki, Stanisław ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Bioavailability; Buccal; Norverapamil; Pharmacokinetics; Verapamil

Indexed keywords

DRUG; NORVERAPAMIL; STAVERAN; UNCLASSIFIED DRUG; VERAPAMIL;

ADULT; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DEVICE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DESIGN; DRUG DETERMINATION; DRUG FORMULATION; DRUG METABOLISM; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MEDICAL PRACTICE; NORMAL HUMAN; PRIORITY JOURNAL; STANDARD; TABLET;

ADHESIVES; ADULT; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CHEMISTRY, PHARMACEUTICAL; FEMALE; HALF-LIFE; HUMANS; MALE; MOUTH MUCOSA; SOLUBILITY; TABLETS; VERAPAMIL;

EID: 0037093772     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00069-8     Document Type: Article

References (21)

1. Verapamil disposition and effect on PQ-intervals after buccal, oral and intarvenous administration
2. Quantitative assay of verapamil in drugs and serum by capillary isotachophoresis
3. Bioadhesive matrix as controlled release dosage form for verapamil hydrochloride
4. Pharmacokinetics of verapamil from an osmotic system with delayed onset
5. Simultaneous first-order and capacity-limited elimination kinetics after oral administration of verapamil
6. Pharmacodynamic profile of verapamil in relation to absolute bioavailability: Investigations with a conventional and controlled release formulation
7. Drug delivery via the mucous membranes of the oral cavity
8. Comparative bioavailability of verapamil from rapidly absorbed and slow release preparations
9. Pharmacokinetics and pharmacodynamics of verapamil following sublingual and oral administration to healthy volunteers
10. Electrophysiologic effects of verapamil metabolites in the isolated heart
11. Mucoadhesive hydrogels
12. Clinical pharmacokinetics of vasodilators
13. Permeability of verapamil hydrochloride through keratinized buccal mucosa in comparison with abdominal skin and its enhancement with d-limonene and Azone
14. Buccal delivery systems using hydrogels
15. Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine
16. Enantioselective distribution of verapamil and norverapamil into human and rat erythrocytes: The role of plasma protein binding
17. The hepatic first-pass metabolism of problematic drugs
18. A validated method for determination of verapamil and norverapamil in human plasma
19. Model podpoliczkowej postaci leku z chlorowodorkiem werapamilu
20. Influence of polyoxyethylene-10-oleylether on in vitro verapamil hydrochloride penetration through mucous membrane from a model buccal drug formulation
21. Stereoselective separations of chiral anticancer drugs and their application to pharmacodynamic and pharmacokinetic studies